Skip to Main Content

Author Details

Mark A Watson
Washington University School of Medicine
1987
134
63
PMIDPaper TitleJournal TitlePublished Year
37029224Automatic detection of circulating tumor cells and cancer associated fibroblasts using deep learning.Sci Rep2023
37229629Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.Cancer Immunol Res2023
35706127Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis.Cancer Res2022
33989287A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.PLoS One2021
37117829Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging.Nat Aging2021
33599688Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial.JAMA Oncol2021
34764307Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.NPJ Breast Cancer2021
34590049Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.JTO Clin Res Rep2021
31613330Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.Am J Clin Pathol2020
31992650Oxidised metabolites of the omega-6 fatty acid linoleic acid activate dFOXO.Life Sci Alliance2020
32717408Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance).J Thorac Oncol2020
32181394Long non-coding RNA <i>LCAL62 / LINC00261</i> is associated with lung adenocarcinoma prognosis.Heliyon2020
31432366Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.Breast Cancer Res Treat2019
30253973Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.J Thorac Oncol2019
26359696Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.Am J Clin Oncol2018
30089255Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.Cell Rep2018
30224629Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.Nat Commun2018
29291741Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.Breast Cancer Res2018
28045625Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).J Clin Oncol2017
28453704Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.Ann Oncol2017
28129357Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.PLoS One2017
27502118Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.Nat Commun2016
26400846Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development.Breast Cancer Res Treat2015
26325296caTissue Suite to OpenSpecimen: Developing an extensible, open source, web-based biobanking management system.J Biomed Inform2015
24211365Validation of a next-generation sequencing assay for clinical molecular oncology.J Mol Diagn2014
23129172Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.Breast Cancer Res Treat2013
23634996Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.N Engl J Med2013
23810758Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.J Mol Diagn2013
23242585A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.Breast Cancer Res Treat2013
22025306Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostate.Prostate2012
22980976Genomic landscape of non-small cell lung cancer in smokers and never-smokers.Cell2012
22722193Whole-genome analysis informs breast cancer response to aromatase inhibition.Nature2012
22706855Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories.Am J Clin Pathol2012
22817890The origin and evolution of mutations in acute myeloid leukemia.Cell2012
22237025Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.Nature2012
22235101Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.Clin Cancer Res2012
20646217Genome-wide polymorphism analysis demonstrates a monoclonal origin of pilocytic astrocytoma.Neuropathol Appl Neurobiol2011
22031304A new paradigm for biospecimen banking in the personalized medicine era.Am J Clin Pathol2011
21555689Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.J Clin Oncol2011
21745356Identification of transcriptional regulatory networks specific to pilocytic astrocytoma.BMC Med Genomics2011
21325289Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.Clin Cancer Res2011
21366430Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.N Engl J Med2011
21505136Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.JAMA2011
19967557A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.Breast Cancer Res Treat2010
21067377DNMT3A mutations in acute myeloid leukemia.N Engl J Med2010
20363916A role for the epithelial microenvironment at tumor boundaries: evidence from Drosophila and human squamous cell carcinomas.Am J Pathol2010
20393555Genome remodelling in a basal-like breast cancer metastasis and xenograft.Nature2010
20362507Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.Lancet Oncol2010
19844788Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.Breast Cancer Res Treat2010
19237659Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.Circulation2009
  • 1 - 50 of 134

Recommended Authors

University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 16
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 2
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 40
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 12
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 22
The Francis Crick Institute
Career Start Year 1994
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 11
Zhujiang Hospital, Southern Medical University
Career Start Year 1993
Number of shared co-authors 2
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Ludwig Institute for Cancer Research Ltd.
Career Start Year 1993
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 20
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 10
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 7
Central Finland Hospital Nova
Career Start Year 1990
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 26
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 34
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 19
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 2
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 15

Collaborators

The Ohio State University
Co-authored papers 20
Current or past members of the College of American Pathologists
Co-authored papers 18
The Ohio State University
Co-authored papers 18
Washington University School of Medicine.
Co-authored papers 17
Washington University School of Medicine
Co-authored papers 16
Co-authored papers 15
Co-authored papers 14
McDonnell Genome Institute, Washington University in St. Louis
Co-authored papers 14
Washington University School of Medicine
Co-authored papers 13
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 13
Washington University School of Medicine
Co-authored papers 13
University of California san francisco
Co-authored papers 12
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 12
Massachusetts General Hospital
Co-authored papers 11
Washington University School of Medicine.
Co-authored papers 11
University of Texas MD Anderson Cancer Center
Co-authored papers 10
Co-authored papers 10
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 9
Washington University School of Medicine
Co-authored papers 9
Institute for Genomic Medicine, Nationwide Children's Hospital
Co-authored papers 9
Washington University School of Medicine in St. Louis
Co-authored papers 8
Co-authored papers 8
Siteman Cancer Center, Washington University School of Medicine
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 7
Washington University
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7